Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
-
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
-
Dublin, July 10, 2026 (GLOBE NEWSWIRE) -- The "Generative AI in Pharmaceutical Market Report 2026" has been added to ResearchAndMarkets.com's offering. The generative artificial intelligence...
-
Dublin, July 06, 2026 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA (Nov 4th - Nov 6th, 2026)" has been added to ResearchAndMarkets.com's offering The Pharma Mini MBA: A three-day accelerated...
-
GNI Group Completes Acquisition of AYUMI Pharmaceutical
-
Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study
-
The report analyzes confectionery ingredients by nature, ingredient type, application and region, with forecasts through 2030.
-
MannKind Awarded Breakthrough T1D Grant to Support Advancement of INHALE-1ST Pediatric Trial of Afrezza® in Youth with Newly-Diagnosed T1D
-
ORION CORPORATION PRESS RELEASE 23 JUNE 2026 at 9:30 EEST Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission Orion...
-
ORION OYJ LEHDISTÖTIEDOTE 23.6.2026 KLO 9.30 Orion Pharman ODM-212-molekyyli on saanut Euroopan komission myöntämän harvinaislääkestatuksen pahanlaatuisen mesoteliooman hoitoon ...